leadf
logo-loader
viewAlba Mineral Resources PLC

Alba finds Amitsoq offers high graphite content and higher-value flakes

A second phase of testing in Greenland has found 36% of the refined product consists of higher-value large, jumbo and super-jumbo flake sizes

Alba Mineral Resources plc -
Graphite is sought for a range of industrial uses

Alba Mineral Resources plc (LON:ALBA) said testing at its Amitsoq project in southern Greenland confirms the potential for an attractive graphite product.

This second phase of testing has found 36% of the refined product consists of higher-value large, jumbo and super-jumbo flake sizes.

READ: Alba Mineral Resources confirms start of Horse Hill horizontal drilling

Executive chairman George Frangeskides said this round of tests confirmed “two very important things” for the future economics of the project.

“Firstly, that a saleable, 97.3% product can be produced. 

“And secondly, that in that refined product is included a significant proportion of the higher-value flake graphite that is sought-after for a range of industrial uses, which still underpin the majority of the demand for natural flake graphite globally.” 

The AIM-listed company said it will now move on to the design of a further phase of refining testwork alongside an assessment of whether Amitsoq can turn out the sort of high-purity product that wanted by the battery metals sector.

“This completed work on one of our key assets provides us with great confidence as we move into 2020,” Frangeskides added.

Alba shares were up 4% to 0.19p on Thursday afternoon.

Quick facts: Alba Mineral Resources PLC

Price: 0.325 GBX

AIM:ALBA
Market: AIM
Market Cap: £20.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Bionomics' positive pharmacokinetic results confirms it can begin second...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

1 day, 8 hours ago

2 min read